WUH: A Prospective Multicenter Randomized Controlled Clinical Study Of NuShield and Standard of Care (SOC) compared to SOC alone For The Management Of Diabetic Foot Ulcers

Brief description of study

The purpose of this study is to better understand the potential healing outcomes of NuShield® and standard of care treatment in diabetic foot ulcers compared to standard of care treatment alone. NuShield® is a dehydrated amnion and chorion membrane graft and has been developed for application as a wound covering for a variety of partial- and full thickness acute and chronic wounds. NuShield® is regulated as a Human Cellular and Tissue Based Product (HCT/P) solely under Section 361 of the Public Health Service Act as defined in 21 CFR Part 1271.HCT/P.

Clinical Study Identifier: s18-01606
ClinicalTrials.gov Identifier: NCT03547635
Principal Investigator: Scott A Gorenstein.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.